iTeos Therapeutics, Inc. (ITOS) SEC filings
ITOS SEC filings moved a median of +0.91% by the close. ITOS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ITOS overview →
34 measured ITOS SEC filing events.
Where these ITOS SEC filings landedvs 29 measured ITOS SEC filing reactions
| Middle 50% of ITOS SEC filing reactions | -2.03% to +4.12% |
|---|---|
| Median reaction (to close) | +0.91% |
| Measured reactions | 29 |
Point-in-time · zero look-ahead
Half of the 29 ITOS SEC filing events with a measured close landed between -2.03% and +4.12%; 59% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G iTeos Therapeutics, Inc. | SEC filing · Form 15-12G | — | — | |
| Form EFFECT iTeos Therapeutics, Inc. | SEC filing · Form EFFECT | — | — | |
| Form 8-K iTeos Therapeutics, Inc. For: Aug 29 | SEC filing · Form 8-K | — | — | |
| Form POS AM iTeos Therapeutics, Inc. | SEC filing · Form POS | — | — | |
| Form S-8 POS iTeos Therapeutics, Inc. | SEC filing · Form S-8 | — | — | |
| Form 10-Q iTeos Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.15% | +0.20% | |
| Form 8-K iTeos Therapeutics, Inc. For: Jul 18 | SEC filing · Form 8-K | -0.14% | -2.03% | |
| Form 8-K iTeos Therapeutics, Inc. For: Jun 17 | SEC filing · Form 8-K | +0.10% | -0.20% | |
| Form 8-K iTeos Therapeutics, Inc. For: Jun 01 | SEC filing · Form 8-K | +0.39% | -0.20% | |
| Form DEFA14A iTeos Therapeutics, Inc. | SEC filing · Form DEFA14A | +0.39% | -0.20% | |
| Form 8-K iTeos Therapeutics, Inc. For: May 27 | SEC filing · Form 8-K | +4.40% | -5.54% | |
| Form 8-K iTeos Therapeutics, Inc. For: May 13 | SEC filing · Form 8-K | -2.83% | -7.54% | |
| Form 10-Q iTeos Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.55% | -5.39% | |
| Form ARS iTeos Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +0.28% | +6.12% | |
| Form DEF 14A iTeos Therapeutics, Inc. For: Jun 17 | SEC filing · Form DEF | +0.28% | +6.12% | |
| Form DEFA14A iTeos Therapeutics, Inc. | SEC filing · Form DEFA14A | +0.28% | +6.12% | |
| Form 10-K iTeos Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.46% | +6.14% | |
| Form S-8 iTeos Therapeutics, Inc. | SEC filing · Form S-8 | +1.46% | +6.14% | |
| Form 8-K iTeos Therapeutics, Inc. For: Jan 13 | SEC filing · Form 8-K | -0.45% | +0.91% | |
| Form 10-Q iTeos Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -3.53% | -4.57% | |
| Form 8-K iTeos Therapeutics, Inc. For: Oct 31 | SEC filing · Form 8-K | -0.60% | +2.40% | |
| Form 8-K iTeos Therapeutics, Inc. For: Sep 14 | SEC filing · Form 8-K | -3.77% | -15.44% | |
| Form 10-Q iTeos Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.55% | -3.45% | |
| Form 8-K iTeos Therapeutics, Inc. For: Jun 11 | SEC filing · Form 8-K | +0.43% | +0.62% | |
| Form 8-K iTeos Therapeutics, Inc. For: May 10 | SEC filing · Form 8-K | -1.06% | -2.07% | |
| Form 10-Q iTeos Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.79% | +4.12% | |
| Form ARS iTeos Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | -1.72% | +1.15% | |
| Form DEF 14A iTeos Therapeutics, Inc. For: Jun 11 | SEC filing · Form DEF | -1.72% | +1.15% | |
| Form DEFA14A iTeos Therapeutics, Inc. | SEC filing · Form DEFA14A | -1.72% | +1.15% | |
| Form 10-K iTeos Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +5.69% | |
| Form S-8 iTeos Therapeutics, Inc. | SEC filing · Form S-8 | +0.00% | +5.69% | |
| Form 8-K iTeos Therapeutics, Inc. For: Jan 10 | SEC filing · Form 8-K | +0.00% | +1.12% | |
| Form 8-K iTeos Therapeutics, Inc. For: Dec 05 | SEC filing · Form 8-K | -2.42% | -0.61% | |
| Form 10-Q iTeos Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +4.31% | +3.20% |
Keep exploring
More ITOS: earnings → · analyst actions → · ITOS overview →